找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Continuous Dopaminergic Stimulation in Parkinson’s Disease; Proceedings of the W J. A. Obeso,R. Horowski,C. D. Marsden Conference proceedin

[復(fù)制鏈接]
樓主: VER
31#
發(fā)表于 2025-3-26 22:38:38 | 只看該作者
https://doi.org/10.1007/978-3-322-80731-1infusion together with a small dose of levodopa (plus DDI) are effective treatment for “on-off” fluctuations in Parkinson’s disease, but the frequency of adverse effects limits the number of patients who can be treated successfully with this technique.
32#
發(fā)表于 2025-3-27 03:04:14 | 只看該作者
33#
發(fā)表于 2025-3-27 07:14:10 | 只看該作者
34#
發(fā)表于 2025-3-27 11:00:59 | 只看該作者
Continuous subcutaneous lisuride infusions in Parkinson’s diseaseinfusion together with a small dose of levodopa (plus DDI) are effective treatment for “on-off” fluctuations in Parkinson’s disease, but the frequency of adverse effects limits the number of patients who can be treated successfully with this technique.
35#
發(fā)表于 2025-3-27 14:18:46 | 只看該作者
Pharmacokinetics of lisuride after subcutaneous infusiontion of the infusion, concentrations declined with a half-life of 1.4 ± 0.4 hour. The total clearance of lisuride was 20 ± 6 ml/min/kg. Due to the low interpatient variability of plasma levels, a good control of clinical effects is to be expected.
36#
發(fā)表于 2025-3-27 18:32:34 | 只看該作者
Lisuride infusion pump in Parkinson’s disease. A report of two casesough a net increase in the number of hours spent “on”. Dyskinesias remained unmodified. Limiting psychiatric side effects were observed in one of the patients..Practical and technical aspects of the management of this therapeutic method are discussed.
37#
發(fā)表于 2025-3-28 00:15:38 | 只看該作者
Pathogenetic studies of motor fluctuations in Parkinson’s diseasete advanced Parkinson’s disease. Since levodopa clearance from the general circulation was found to be similar in patients with wearing-off or on-off phenomena and those with a stable response to levodopa, peripheral pharmacokinetic factors are unlikely to be involved. Efficacy half-time for levodop
38#
發(fā)表于 2025-3-28 05:37:09 | 只看該作者
The case for and concerns about continuous dopamine stimulation in Parkinson’s diseaseluctations in response (“on-off”). This should be manageable with innovative delivery systems for the drugs. However further studies are required to determine if continuous dopaminergic stimulation will be complicated by increased levels of drug metabolites or down regulation of dopaminergic neurotr
39#
發(fā)表于 2025-3-28 07:24:51 | 只看該作者
40#
發(fā)表于 2025-3-28 12:56:34 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 10:37
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
乡城县| 内丘县| 汕尾市| 镇巴县| 葫芦岛市| 大兴区| 阿拉善右旗| 新干县| 桃江县| 北川| 鞍山市| 敖汉旗| 青神县| 余江县| 新化县| 千阳县| 望城县| 循化| 吉林省| 石泉县| 营山县| 沿河| 广平县| 东乌珠穆沁旗| 方正县| 绥中县| 海南省| 高邑县| 从化市| 广德县| 建平县| 綦江县| 墨脱县| 汉中市| 天门市| 辽宁省| 隆回县| 汝阳县| 大新县| 泰顺县| 嘉荫县|